16445329

Source:http://linkedlifedata.com/resource/pubmed/id/16445329

Download in:

Switch to

Custom View

Named Graph Language Inference

Statements in which the resource exists as a subject.
Predicate	Object
rdf:type	pubmed:Citation
lifeskim:mentions	umls-concept:C0004334, umls-concept:C0038257, umls-concept:C0040053, umls-concept:C0205178, umls-concept:C0291448, umls-concept:C1261287, umls-concept:C1280500
pubmed:issue	1
pubmed:dateCreated	2006-1-31
pubmed:abstractText	To investigate if a platelet inhibitor (aurintricarboxylic acid [ATA]) and a heparin-mimicking antagonist (RG-13577) of basic fibroblast growth factor 2 (bFGF2) could be combined as a stable compound and attached to conventional bare metal stents to hinder thrombus formation and inflammatory reactions of stenting.
pubmed:language	eng
pubmed:journal	http://linkedlifedata.com/resource/pubmed/journal/100896915
pubmed:citationSubset	IM
pubmed:chemical	http://linkedlifedata.com/resource/pubmed/chemical/2-(4-hydroxyphenoxy)acetic..., http://linkedlifedata.com/resource/pubmed/chemical/Aurintricarboxylic Acid, http://linkedlifedata.com/resource/pubmed/chemical/Drug Combinations, http://linkedlifedata.com/resource/pubmed/chemical/Fibroblast Growth Factor 2, http://linkedlifedata.com/resource/pubmed/chemical/Phenoxyacetates, http://linkedlifedata.com/resource/pubmed/chemical/Platelet Aggregation Inhibitors, http://linkedlifedata.com/resource/pubmed/chemical/Polymers
pubmed:status	MEDLINE
pubmed:month	Feb
pubmed:issn	1526-6028
pubmed:author	pubmed-author:Ben-SassonShmuel ASA, pubmed-author:GaramvölgyiRitaR, pubmed-author:GlogarDietmarD, pubmed-author:GyöngyösiMariannM, pubmed-author:HevesiAkosA, pubmed-author:LotanChaimC, pubmed-author:OrlowskiMichaelM, pubmed-author:PetrasiZsoltZ, pubmed-author:PugatschTheaT, pubmed-author:ShiraziMaryamM, pubmed-author:SperkerWolfgangW, pubmed-author:StrehblowChristophC, pubmed-author:SylvénChristerC, pubmed-author:WeissThomasT
pubmed:issnType	Print
pubmed:volume	13
pubmed:owner	NLM
pubmed:authorsComplete	Y
pubmed:pagination	94-103
pubmed:dateRevised	2006-11-15
pubmed:meshHeading	pubmed-meshheading:16445329-Animals, pubmed-meshheading:16445329-Aurintricarboxylic Acid, pubmed-meshheading:16445329-Coronary Angiography, pubmed-meshheading:16445329-Coronary Restenosis, pubmed-meshheading:16445329-Coronary Vessels, pubmed-meshheading:16445329-Drug Combinations, pubmed-meshheading:16445329-Drug Evaluation, Preclinical, pubmed-meshheading:16445329-Fibroblast Growth Factor 2, pubmed-meshheading:16445329-Hyperplasia, pubmed-meshheading:16445329-Microscopy, Electron, Scanning, pubmed-meshheading:16445329-Phenoxyacetates, pubmed-meshheading:16445329-Platelet Aggregation Inhibitors, pubmed-meshheading:16445329-Polymers, pubmed-meshheading:16445329-Stents, pubmed-meshheading:16445329-Swine, pubmed-meshheading:16445329-Thrombosis, pubmed-meshheading:16445329-Treatment Failure, pubmed-meshheading:16445329-Tunica Intima
pubmed:year	2006
pubmed:articleTitle	Paradoxical effects of aurintricarboxylic acid and RG-13577: acute thrombosis and in-stent stenosis in a passive-coated stent.
pubmed:affiliation	Division of Cardiology, Department of Internal Medicine II, Medical University of Vienna, Austria, and Departmetn of Cardiology, Karolinska University Hospital at Huddinge, Stockholm, Sweden. Christoph.Strehblow@wienkav.at
pubmed:publicationType	Journal Article, Comparative Study